Cetirizine hydrochloride and Ibrance drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cetirizine hydrochloride (cetirizine hydrochloride) and Ibrance (palbociclib). Common drug interactions include hot flush among females and leukopenia among males.

The phase IV clinical study analyzes what interactions people have when they take Cetirizine hydrochloride and Ibrance. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Cetirizine hydrochloride?

Cetirizine hydrochloride has active ingredients of cetirizine hydrochloride. It is often used in allergies. eHealthMe is studying from 34,903 Cetirizine hydrochloride users. Check the latest studies of Cetirizine hydrochloride.

What is Ibrance?

Ibrance has active ingredients of palbociclib. eHealthMe is studying from 104,433 Ibrance users. Check the latest studies of Ibrance.

On Nov, 12, 2025

40 people who take Cetirizine hydrochloride and Ibrance together, and have interactions are studied.

Cetirizine hydrochloride and Ibrance drug interactions.

What are the common drug interactions of Cetirizine Hydrochloride and Ibrance, by gender? *:

female:

Hot flush (sudden feelings of heat)
Hysterectomy
Memory impairment
White blood cell count increased
Neutropenia (an abnormally low number of neutrophils)
Alopecia (absence of hair from areas of the body)
Diarrhoea
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Nausea (feeling of having an urge to vomit)
Breast pain

male:

Leukopenia (less number of white blood cells in blood)
Lymphopenia (an abnormally low level of lymphocytes in the blood)
Neutropenia (an abnormally low number of neutrophils)

What are the common drug interactions of Cetirizine Hydrochloride and Ibrance, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Abdominal discomfort
Alopecia (absence of hair from areas of the body)
Fatigue (feeling of tiredness)
Migraine (headache)
Neuropathy peripheral (surface nerve damage)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Pruritus (severe itching of the skin)
Rash vesicular (rash with a small bubble)
Sensory loss (senses loss)

30-39:

n/a

40-49:

Neoplasm progression (growth of tumour)
Asthenia (weakness)
Decreased interest
Fatigue (feeling of tiredness)
Hot flush (sudden feelings of heat)
Hysterectomy
Memory impairment
White blood cell count decreased
White blood cell count increased
Abdominal distension

50-59:

Leukopenia (less number of white blood cells in blood)
Lymphopenia (an abnormally low level of lymphocytes in the blood)
Neutropenia (an abnormally low number of neutrophils)

60+:

White blood cell count decreased
Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
Dizziness
Nasopharyngitis (inflammation of the nasopharynx)
Hypersensitivity
Rash
Upper-airway cough syndrome
Abdominal pain upper
Ankle fracture
Chest pain

What are the existing conditions these people have? *

Breast Cancer: 13 people, 32.50%
Pain: 12 people, 30.00%
Itching: 12 people, 30.00%
Hiv Test Positive: 10 people, 25.00%
Dyslipidaemia (abnormal amount of lipids): 10 people, 25.00%
Diabetes: 10 people, 25.00%
Breast Cancer Male: 10 people, 25.00%
Breast Cancer Female: 8 people, 20.00%
Breast Cancer Metastatic: 3 people, 7.50%
Laxative Supportive Care: 2 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cetirizine hydrochloride and Ibrance?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously